BCRP/ABCG2 Substrates
DBCAT002663Pharmacologic class
A DrugBank category of 191 drugs. 168 of them are approved.
- Also known as
- BCRP substrates · BCRP/ABCG2-Substrates · Breast cancer resistance protein substrates
- Drugs
- 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a
- Abemaciclib
- Acoramidis
- Afatinib
- Allopurinol
- Almonertinib
- Alpelisib
- Alvocidib
- Amisulpride
- Apixaban
- Aprocitentan
- Artesunate
- Asciminib
- Atogepant
- Avutometinib
- Baricitinib
- Baxdrostat
- Berotralstat
- Binimetinib
- Brensocatib
- Brigatinib
- Cabotegravir
- Camptothecin
- Carboplatin
- Cefbuperazone
What you can answer from here — as of May 25, 2021
Which targets do BCRP/ABCG2 Substrates share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account